Publication|Articles|December 18, 2024
- Pharmaceutical Executive: December 2024
- Volume 44
- Issue 12
Pharmaceutical Executive: December 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
Trending Forwardover 1 year ago
Pharma’s ‘Best-Kept Secret’over 1 year ago
Seeking More Value, Less Costover 1 year ago
Dealmaking Dormant No Moreover 1 year ago
A Rocky Road for Regulationover 1 year ago
DTC's New Era of Engagementover 1 year ago
Holding On Tight to AI Waveover 1 year ago
The Recipe for Relief: Overcoming Industry Pain Pointsover 1 year ago
Pharma Forecasting: Key Markets Investors Can’t IgnoreAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
5